Industry: Chemical & Material
Published Date: 2025-02-21
Pages: 77 Pages
Report ld: 4164192
Request Sample
Customized Report
The global Fosfomycin market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Fosfomycin (also known as phosphomycin or phosphonomycin and the trade names Monurol and Monuril) is a broad-spectrum antibiotic produced by certain Streptomyces species, although it can now be made by chemical synthesis.
The North America Fosfomycin market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Fosfomycin include Northeast Pharm, Ercros, Shinpoong Pharm, Interquim, Manus Aktteva Biopharma LLP, Selectchemie, Hunan Huana Pharmaceuticals, Hubei Xunda Pharmaceutical Co.,Ltd., Guilin Hwasun, FarmaSino Pharmaceutical, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Fosfomycin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fosfomycin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Fosfomycin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Fosfomycin manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fosfomycin revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Fosfomycin Product Scope
1.2 Fosfomycin by Type
1.2.1 Global Fosfomycin Sales by Type (2020 & 2024 & 2031)
1.2.2 Fosfomycin Calcium
1.2.3 Fosfomycin Sodium
1.2.4 Fosfomycin Trometamol
1.3 Fosfomycin by Application
1.3.1 Global Fosfomycin Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Injection Drugs
1.3.3 Oral Drugs
1.4 Global Fosfomycin Market Estimates and Forecasts (2020-2031)
1.4.1 Global Fosfomycin Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Fosfomycin Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Fosfomycin Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Fosfomycin Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Fosfomycin Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Fosfomycin Sales Market Share by Region (2020-2025)
2.2.2 Global Fosfomycin Revenue Market Share by Region (2020-2025)
2.3 Global Fosfomycin Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Fosfomycin Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Fosfomycin Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Fosfomycin Market Size and Prospective (2020-2031)
2.4.2 Europe Fosfomycin Market Size and Prospective (2020-2031)
2.4.3 China Fosfomycin Market Size and Prospective (2020-2031)
2.4.4 Japan Fosfomycin Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Fosfomycin Historic Market Review by Type (2020-2025)
3.1.1 Global Fosfomycin Sales by Type (2020-2025)
3.1.2 Global Fosfomycin Revenue by Type (2020-2025)
3.1.3 Global Fosfomycin Price by Type (2020-2025)
3.2 Global Fosfomycin Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Fosfomycin Sales Forecast by Type (2026-2031)
3.2.2 Global Fosfomycin Revenue Forecast by Type (2026-2031)
3.2.3 Global Fosfomycin Price Forecast by Type (2026-2031)
3.3 Different Types Fosfomycin Representative Players
4 Global Market Size by Application
4.1 Global Fosfomycin Historic Market Review by Application (2020-2025)
4.1.1 Global Fosfomycin Sales by Application (2020-2025)
4.1.2 Global Fosfomycin Revenue by Application (2020-2025)
4.1.3 Global Fosfomycin Price by Application (2020-2025)
4.2 Global Fosfomycin Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Fosfomycin Sales Forecast by Application (2026-2031)
4.2.2 Global Fosfomycin Revenue Forecast by Application (2026-2031)
4.2.3 Global Fosfomycin Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Fosfomycin Application
5 Competition Landscape by Players
5.1 Global Fosfomycin Sales by Players (2020-2025)
5.2 Global Top Fosfomycin Players by Revenue (2020-2025)
5.3 Global Fosfomycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fosfomycin as of 2024)
5.4 Global Fosfomycin Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Fosfomycin, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Fosfomycin, Product Type & Application
5.7 Global Key Manufacturers of Fosfomycin, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Fosfomycin Sales by Company
6.1.1.1 North America Fosfomycin Sales by Company (2020-2025)
6.1.1.2 North America Fosfomycin Revenue by Company (2020-2025)
6.1.2 North America Fosfomycin Sales Breakdown by Type (2020-2025)
6.1.3 North America Fosfomycin Sales Breakdown by Application (2020-2025)
6.1.4 North America Fosfomycin Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Fosfomycin Sales by Company
6.2.1.1 Europe Fosfomycin Sales by Company (2020-2025)
6.2.1.2 Europe Fosfomycin Revenue by Company (2020-2025)
6.2.2 Europe Fosfomycin Sales Breakdown by Type (2020-2025)
6.2.3 Europe Fosfomycin Sales Breakdown by Application (2020-2025)
6.2.4 Europe Fosfomycin Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Fosfomycin Sales by Company
6.3.1.1 China Fosfomycin Sales by Company (2020-2025)
6.3.1.2 China Fosfomycin Revenue by Company (2020-2025)
6.3.2 China Fosfomycin Sales Breakdown by Type (2020-2025)
6.3.3 China Fosfomycin Sales Breakdown by Application (2020-2025)
6.3.4 China Fosfomycin Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Fosfomycin Sales by Company
6.4.1.1 Japan Fosfomycin Sales by Company (2020-2025)
6.4.1.2 Japan Fosfomycin Revenue by Company (2020-2025)
6.4.2 Japan Fosfomycin Sales Breakdown by Type (2020-2025)
6.4.3 Japan Fosfomycin Sales Breakdown by Application (2020-2025)
6.4.4 Japan Fosfomycin Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Northeast Pharm
7.1.1 Northeast Pharm Company Information
7.1.2 Northeast Pharm Business Overview
7.1.3 Northeast Pharm Fosfomycin Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Northeast Pharm Fosfomycin Products Offered
7.1.5 Northeast Pharm Recent Development
7.2 Ercros
7.2.1 Ercros Company Information
7.2.2 Ercros Business Overview
7.2.3 Ercros Fosfomycin Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Ercros Fosfomycin Products Offered
7.2.5 Ercros Recent Development
7.3 Shinpoong Pharm
7.3.1 Shinpoong Pharm Company Information
7.3.2 Shinpoong Pharm Business Overview
7.3.3 Shinpoong Pharm Fosfomycin Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Shinpoong Pharm Fosfomycin Products Offered
7.3.5 Shinpoong Pharm Recent Development
7.4 Interquim
7.4.1 Interquim Company Information
7.4.2 Interquim Business Overview
7.4.3 Interquim Fosfomycin Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Interquim Fosfomycin Products Offered
7.4.5 Interquim Recent Development
7.5 Manus Aktteva Biopharma LLP
7.5.1 Manus Aktteva Biopharma LLP Company Information
7.5.2 Manus Aktteva Biopharma LLP Business Overview
7.5.3 Manus Aktteva Biopharma LLP Fosfomycin Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Manus Aktteva Biopharma LLP Fosfomycin Products Offered
7.5.5 Manus Aktteva Biopharma LLP Recent Development
7.6 Selectchemie
7.6.1 Selectchemie Company Information
7.6.2 Selectchemie Business Overview
7.6.3 Selectchemie Fosfomycin Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Selectchemie Fosfomycin Products Offered
7.6.5 Selectchemie Recent Development
7.7 Hunan Huana Pharmaceuticals
7.7.1 Hunan Huana Pharmaceuticals Company Information
7.7.2 Hunan Huana Pharmaceuticals Business Overview
7.7.3 Hunan Huana Pharmaceuticals Fosfomycin Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Hunan Huana Pharmaceuticals Fosfomycin Products Offered
7.7.5 Hunan Huana Pharmaceuticals Recent Development
7.8 Hubei Xunda Pharmaceutical Co.,Ltd.
7.8.1 Hubei Xunda Pharmaceutical Co.,Ltd. Company Information
7.8.2 Hubei Xunda Pharmaceutical Co.,Ltd. Business Overview
7.8.3 Hubei Xunda Pharmaceutical Co.,Ltd. Fosfomycin Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Hubei Xunda Pharmaceutical Co.,Ltd. Fosfomycin Products Offered
7.8.5 Hubei Xunda Pharmaceutical Co.,Ltd. Recent Development
7.9 Guilin Hwasun
7.9.1 Guilin Hwasun Company Information
7.9.2 Guilin Hwasun Business Overview
7.9.3 Guilin Hwasun Fosfomycin Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Guilin Hwasun Fosfomycin Products Offered
7.9.5 Guilin Hwasun Recent Development
7.10 FarmaSino Pharmaceutical
7.10.1 FarmaSino Pharmaceutical Company Information
7.10.2 FarmaSino Pharmaceutical Business Overview
7.10.3 FarmaSino Pharmaceutical Fosfomycin Sales, Revenue and Gross Margin (2020-2025)
7.10.4 FarmaSino Pharmaceutical Fosfomycin Products Offered
7.10.5 FarmaSino Pharmaceutical Recent Development
8 Fosfomycin Manufacturing Cost Analysis
8.1 Fosfomycin Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Fosfomycin
8.4 Fosfomycin Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Fosfomycin Distributors List
9.3 Fosfomycin Customers
10 Fosfomycin Market Dynamics
10.1 Fosfomycin Industry Trends
10.2 Fosfomycin Market Drivers
10.3 Fosfomycin Market Challenges
10.4 Fosfomycin Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Fosfomycin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 133
USD 3950.00
(Single User License)
The global Fosfomycin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-25
Pages: 126
USD 2900.00
(Single User License)
The global Fosfomycin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 135
USD 4900.00
(Single User License)
The global market for Fosfomycin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-21
Pages: 91
USD 2900.00
(Single User License)
The global market for Fosfomycin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 97
USD 3950.00
(Single User License)
Fosfomycin (also known as phosphomycin or phosphonomycin and the trade names Monurol and Monuril) is a broad-spectrum antibiotic produced by certain Streptomyces species, although it can now be made by chemical synthesis.
Published Date: 2024-04-06
Pages: 105
USD 4900.00
(Single User License)
Fosfomycin (also known as phosphomycin or phosphonomycin and the trade names Monurol and Monuril) is a broad-spectrum antibiotic produced by certain Streptomyces species, although it can now be made by chemical synthesis.
Published Date: 2024-01-07
Pages: 97
USD 2900.00
(Single User License)
The global market for Fosfomycin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 133
The global Fosfomycin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-25
Pages: 126
The global Fosfomycin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 135
The global market for Fosfomycin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-21
Pages: 91
The global market for Fosfomycin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 97
Fosfomycin (also known as phosphomycin or phosphonomycin and the trade names Monurol and Monuril) is a broad-spectrum antibiotic produced by certain Streptomyces species, although it can now be made by chemical synthesis.
Published: 2024-04-06
Pages: 105
Fosfomycin (also known as phosphomycin or phosphonomycin and the trade names Monurol and Monuril) is a broad-spectrum antibiotic produced by certain Streptomyces species, although it can now be made by chemical synthesis.
Published: 2024-01-07
Pages: 97
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now